المؤلفون: Ramsey ML; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Heald B; Medical Affairs, Invitae Corporation, San Francisco, California, United States of America., Gokun Y; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Baker J; Division of Human Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Groce JR; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Han S; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Hart PA; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Krishna SG; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Lara LF; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Lee PJ; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Papachristou GI; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Pearlman R; Division of Human Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Poll S; Medical Affairs, Invitae Corporation, San Francisco, California, United States of America., Roberts ME; Division of Human Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Stanich PP; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.

المصدر: PloS one [PLoS One] 2024 Aug 22; Vol. 19 (8), pp. e0307076. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Testing*/methods , Pancreatitis, Chronic*/genetics , Pancreatitis, Chronic*/diagnosis , Genetic Predisposition to Disease* , Germ-Line Mutation*, Humans ; Adult ; Female ; Male ; Middle Aged ; Aged ; Pancreatitis/genetics ; Pancreatitis/diagnosis ; Young Adult ; Adolescent ; Acute Disease ; Child

المؤلفون: Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Blondeaux E; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Molinelli C; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Bas R; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Di Meglio A; Cancer Survivorship Group, INSERM U981, Gustave Roussy, Villejuif, France., Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center affiliated to Tel Aviv University, Tel Hashomer, Israel., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Agostinetto E; Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Lopetegui-Lia N; Department of Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Division of Oncology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France.; Unité INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France.; Hopital Femme Mère Enfant, Hospice civils de Lyon, Bron, France., Acheritogaray M; Department of Gynecology, Cote Basque Hospital Center, Bayonne, France., Ferrari A; Hereditary Breast and Ovarian Cancer (HBOC) Unit and General Surgery 3 - Senology, Breast Cancer Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; University of Pavia, Pavia, Italy., Paluch-Shimon S; Sharett institute of oncology, Hadassah University Hospital & Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; UO Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada., Vernieri C; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Oncology and Hematology-Oncology Department, University of Milan, Milano, Italy., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute and Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Medical Oncology, Yale University, New Haven, Connecticut, USA., Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion - TecSalud, Tecnologico de Monterrey, Monterrey, Mexico., De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.; Medical Oncology Department of Hematology, Oncology, Dermatology, Umberto 1 University Hospital, Rome, Italy., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy., Vasconcelos de Matos L; Breast Cancer Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Mariño M; Hospital Universitari Son Espases Palma, Palma, Spain., Teixeira L; Department of Senology, Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Saint Louis University Hospital, Paris, France., Graffeo R; Oncology Institute of Southern Switzerland, EOC-IOSI, Bellinzona, Switzerland., Rognone A; Department of Oncology, IRCCS Ospedale San Raffaele, Milano, Italy., Chirco A; Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Antone N; Institute of Oncology 'Ion Chiricuta', Cluj-Napoca, Romania., Abdou Y; University of North Carolina - Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Marhold M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Božović-Spasojević I; Institute for Oncology and Radiology of Serbia, University of Belgrade, Faculty of Medicine, Belgrade, Serbia., Cortés Salgado A; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Carmisciano L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Bruzzone M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Curigliano G; Early Drug Development for Innovative Therapies Division, IRCCS European Institute of Oncology (IEO), Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Cancer and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Institute of Oncology (IOB)-Hospital Quirón Salud, Barcelona, Spain., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

المصدر: Cancer [Cancer] 2024 Aug 15; Vol. 130 (16), pp. 2746-2762. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/metabolism , Germ-Line Mutation* , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , BRCA1 Protein*/genetics , BRCA2 Protein*/genetics, Humans ; Female ; Retrospective Studies ; Adult ; Young Adult ; Disease-Free Survival ; Prognosis

المؤلفون: Kawamoto Y; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Yamai T; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan.; Department of Gastroenterology, Osaka General Medical Center, Osaka, Japan., Ikezawa K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan. ikezawa-ke@oici.jp., Seiki Y; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Watsuji K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Hirao T; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Urabe M; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Kai Y; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Takada R; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Mukai K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Nakabori T; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Uehara H; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan., Inoue T; Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan., Fujisawa F; Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan.; Department of Medical Oncology, Shiga General Hospital, Shiga, Japan., Ohkawa K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chou-ku, Osaka, 541-8567, Japan.

المصدر: BMC cancer [BMC Cancer] 2024 Aug 12; Vol. 24 (1), pp. 1000. Date of Electronic Publication: 2024 Aug 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Phthalazines*/therapeutic use , Germ-Line Mutation* , Pancreatic Neoplasms*/genetics , Pancreatic Neoplasms*/drug therapy , Piperazines*/therapeutic use , Piperazines*/administration & dosage , BRCA2 Protein*/genetics , BRCA1 Protein*/genetics , Genetic Predisposition to Disease*, Humans ; Middle Aged ; Female ; Aged ; Male ; Adult ; Retrospective Studies ; Aged, 80 and over ; Maintenance Chemotherapy ; Genetic Testing/methods ; Clinical Relevance

المؤلفون: Sylvester MA; College of Medicine, University of Arizona Medical Center-University Campus, Tucson, Arizona, USA., Kumar A; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA., Baban FS; Department of Anatomical Pathology, Mayo Clinic, Rochester, Minnesota, USA., De Vitis LA; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA devitis.la@gmail.com.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1302-1304. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Germ-Line Mutation* , DNA Helicases*/genetics , Adenocarcinoma, Clear Cell*/genetics , Adenocarcinoma, Clear Cell*/pathology , Transcription Factors*/genetics , Nuclear Proteins*/genetics, Humans ; Female ; Middle Aged ; Mullerian Ducts/abnormalities ; Mullerian Ducts/pathology ; Adult ; Uterine Neoplasms/genetics ; Uterine Neoplasms/pathology

المؤلفون: Soukupova J; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Stastna B; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.; Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic., Kanwal M; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Hojny J; Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Zemankova P; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Borecka M; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Cerna L; Centre for Medical Genetics and Reproductive Medicine, GENNET, Prague, Czech Republic., Cerna M; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Cerna M; Institute of Medical Genetics, University Hospital Pilsen, Pilsen, Czech Republic., Curtisova V; Department of Medical Genetics, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University, Olomouc, Czech Republic., Dolezalova T; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Duskova P; Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Havranek O; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic., Horackova K; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Hovhannisyan M; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Hruskova L; Department of Medical Genetics, GHC Genetics, Prague, Czech Republic., Chvojka S; Centre for Medical Genetics and Reproductive Medicine, GENNET, Prague, Czech Republic., Janatova M; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Janikova M; Department of Medical Genetics, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University, Olomouc, Czech Republic., Jelinkova S; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Just P; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Kalousova M; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Kleiblova P; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Kosarova M; Department of Medical Genetics, Pronatal, Prague, Czech Republic., Koudova M; Centre for Medical Genetics and Reproductive Medicine, GENNET, Prague, Czech Republic., Kral J; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Krausova M; Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Krutilkova V; Department of Medical Genetics, AGEL Laboratories, AGEL Research and Training Institute, Novy Jicin, Czech Republic., Machackova E; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Matejkova K; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Prague, Czech Republic., Michalovska R; Department of Medical Genetics, GHC Genetics, Prague, Czech Republic., Nehasil P; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Nemcova B; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Novotny J; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Palek M; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Pesek P; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Safarikova M; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Scheinost O; Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic., Springer D; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Stolarova L; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Stranecky V; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Subrt I; Institute of Medical Genetics, University Hospital Pilsen, Pilsen, Czech Republic., Tavandzis S; Department of Medical Genetics, AGEL Laboratories, AGEL Research and Training Institute, Novy Jicin, Czech Republic., Tureckova E; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Vesela K; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Vlckova Z; Department of Medical Genetics, GHC Genetics, Prague, Czech Republic., Vocka M; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Zima T; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Macurek L; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Kleibl Z; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.

مؤلفون مشاركون: CZECANCA consortium

المصدر: Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (16), pp. e70103.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Germ-Line Mutation* , Genetic Predisposition to Disease* , Breast Neoplasms*/genetics , Ovarian Neoplasms*/genetics , Fanconi Anemia Complementation Group G Protein*/genetics, Humans ; Female ; Middle Aged ; Adult ; DNA Repair/genetics ; Case-Control Studies ; Aged

المؤلفون: Ronchini C; DIMA Laboratory, Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Gigli F; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Fontanini M; DIMA Laboratory, Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Furgi R; DIMA Laboratory, Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Amato V; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Giglio F; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Gregato G; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Bertolini F; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Rondoni M; Hematology Unit and Metropolitan Romagna Transplant Network, University of Bologna, Ravenna, Italy., Lanza F; Hematology Unit and Metropolitan Romagna Transplant Network, University of Bologna, Ravenna, Italy., Billio A; Division of Hematology and Transplant Unit, Ospedale di Bolzano, Bolzano, Italy., Derenzini E; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Health Sciences, University of Milan, Milan, Italy., Tarella C; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Health Sciences, University of Milan, Milan, Italy., Pelicci PG; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Alcalay M; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Todisco E; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Ospedale di Busto Arsizio, ASST Valle Olona, Busto Arsizio, Italy.

المصدر: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Aug; Vol. 7 (8), pp. e2141.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/diagnosis , Genetic Predisposition to Disease* , Germ-Line Mutation* , Pedigree*, Humans ; Female ; Male ; Middle Aged ; Adult ; DEAD-box RNA Helicases/genetics ; Aged

المؤلفون: Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico. Electronic address: ogar@unam.mx., Caballé-Pérez E; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico. Electronic address: ecaballep@gmail.com., Hernández-Pedro N; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico. Electronic address: nhernandezp@incan.edu.mx., Romero-Nuñez E; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico. Electronic address: eunice.romero@gmail.com., Lucio-Lozada J; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico. Electronic address: josemarialuciounam@gmail.com., Castillo-Ruiz C; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico. Electronic address: cesalpit@bq.unam.mx., Acevedo-Castillo K; Genomic Diagnosis Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico. Electronic address: karlaacevedo.cy@gmail.com., María Álvarez-Gómez R; Hereditary Cancer Clinic, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico. Electronic address: rosamag2@hotmail.com., Molina-Garay C; Genomic Diagnosis Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico. Electronic address: carolina.molina@inmegen.gob.mx., Jiménez-Olivares M; Genomic Diagnosis Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico. Electronic address: mjimenez@inmegen.edu.mx., Carrillo-Sánchez K; Genomic Diagnosis Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico. Electronic address: kcarrillo@inmegen.gob.mx., Cristina Mendoza-Caamal E; Genomic Diagnosis Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico. Electronic address: emendoza@inmegen.gob.mx., Cardona AF; Thoracic Oncology Unit and Direction of Research, Science and Education, Luis Carlos Sarmiento Angulo, Cancer Treatment and Research Center (CTIC), Bogotá, Colombia. Electronic address: acardona@fctic.org., Remon J; Gustave Roussy Cancer Campus, Medical Oncology Department, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: jremon@hmhospitales.com., Alaez-Verson C; Genomic Diagnosis Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico. Electronic address: calaez@inmegen.gob.mx.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Aug; Vol. 194, pp. 107864. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Germ-Line Mutation* , Genetic Predisposition to Disease* , Adenocarcinoma of Lung*/genetics , Adenocarcinoma of Lung*/epidemiology , Adenocarcinoma of Lung*/pathology , Lung Neoplasms*/genetics , Lung Neoplasms*/epidemiology , Lung Neoplasms*/pathology, Humans ; Male ; Female ; Middle Aged ; Cross-Sectional Studies ; Prevalence ; Aged ; Adult ; Genetic Testing/methods ; Cohort Studies ; Checkpoint Kinase 2/genetics

المؤلفون: Qi XP; Department of Oncologic and Urologic Surgery, the 903rd Hospital of People's Liberation Army, Hangzhou Medical College, Hangzhou 310004, China., Chen WY; Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Enze Hospital of Hangzhou Medical College, Taizhou Enze Medical Center (Group), Taizhou 317000, China., Fang XD; Department of Oncologic and Urologic Surgery, the 903rd Hospital of People's Liberation Army, Hangzhou Medical College, Hangzhou 310004, China., Lian BJ; Department of Oncologic and Urologic Surgery, the 903rd Hospital of People's Liberation Army, Hangzhou Medical College, Hangzhou 310004, China., Yu HY; Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Enze Hospital of Hangzhou Medical College, Taizhou Enze Medical Center (Group), Taizhou 317000, China., Wang JW; Department of Emergency and Critical Medicine, Tiantai People's Hospital of Zhejiang Province, Taizhou 317200, China.

المصدر: Zhonghua wai ke za zhi [Chinese journal of surgery] [Zhonghua Wai Ke Za Zhi] 2024 Aug 01; Vol. 62 (8), pp. 798-804.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Zhonghua yi xue hui, Wai ke xue hui Country of Publication: China NLM ID: 0153611 Publication Model: Print Cited Medium: Print ISSN: 0529-5815 (Print) Linking ISSN: 05295815 NLM ISO Abbreviation: Zhonghua Wai Ke Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Pheochromocytoma*/genetics , Germ-Line Mutation* , Paraganglioma*/genetics , Adrenal Gland Neoplasms*/genetics , Adrenal Gland Neoplasms*/diagnosis, Humans ; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics ; Male ; Female

المؤلفون: Franco S; Department of Medicine, Northwestern Medicine, Chicago, IL 60611, United States of America., Godley LA; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America. Electronic address: lucy.godley@northwestern.edu.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 235-240. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Germ-Line Mutation* , Ovarian Neoplasms*/genetics , Breast Neoplasms*/genetics , Genetic Predisposition to Disease*, Humans ; Female ; Neoplasms, Second Primary/genetics ; Neoplasms, Second Primary/epidemiology ; Ataxia Telangiectasia Mutated Proteins/genetics ; Checkpoint Kinase 2/genetics ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Hematologic Neoplasms/genetics ; Genes, BRCA2 ; Fanconi Anemia Complementation Group N Protein

المؤلفون: Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Nipp RD; University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK.

المصدر: JCO oncology practice [JCO Oncol Pract] 2024 Aug; Vol. 20 (8), pp. 1012-1015. Date of Electronic Publication: 2024 May 08.

نوع المنشور: Editorial

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/genetics , Pancreatic Neoplasms*/therapy , Pancreatic Neoplasms*/diagnosis , Germ-Line Mutation* , Genetic Testing*/methods , Genetic Testing*/standards, Humans ; Genetic Predisposition to Disease